Mananquil, Jheliefe F.
HRN: 21-61-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
CEFUROXIME 1.5GM (VIAL)
07/27/2022
07/28/2022
IVT
1.5gms
Q8H X 3 Doses
Post CS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes